Novovision, a leading information technology provider for anatomic pathology (AP) laboratories, announces a new cost-effective price structure for customization of its NovoPath™ platform and related healthcare IT applications. NovoPath™, the company’s flagship product, is one of the industry’s leading AP lab workflow management, specimen tracking and reporting platforms. The new program will benefit both new and existing customers.
According to Wally Soufi, Novovision CEO, “Strategically developed software customizations fine-tuned to a site’s needs can significantly enhance workflow efficiencies and reduce costs. However, most healthcare facilities—anatomic labs included—are facing shrinking reimbursements and want to pare down expenditures, while realizing a rapid return on investment.” Novovision’s new price structure was specifically developed to enable all our customers to benefit from specialized Novovision features and functionalities in today’s demanding healthcare financial environment.
Novovision’s NovoPath™ delivers enhanced communications, productivity and accuracy in more than 100 laboratories nationwide. The company’s product line also includes NovoVoice™, a state-of-the-art digital dictation system, and NovoArchive™, an advanced tool to archive, retrieve and manage digital media.
About Novovision, Inc.
Since its inception in 1993, Novovision, Inc. (novovision.com) has been dedicated to providing specialty healthcare IT solutions that enhance overall quality-of-service and patient care, while streamlining workflow and boosting financial performance. In 1999, Novovision launched its flagship product NovoPath™, a full-featured anatomic pathology lab management software platform. Today, its growing family of high-performance offerings also includes NovoArchive™, an electronic document management system, and NovoVoice™, an advanced transcription and voice dictation management solution.
For more information, visit the website or contact Novovision at sales[.]novovision.com or 877-668-6123. Novovision is based in Princeton, NJ.